A61K 31/7016
Disaccharides
Official title: Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K31/7032)
A61K31/7016 (Disaccharides) appears on 611 US grants and 1,125 published applications in this corpus.
Search patents in A61K- Granted patents
- 611
- Published applications
- 1,125
- Assignees
- 562
- Inventors
- 1,919
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 7 | 0 |
| 1999 | 10 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 3 |
| 2002 | 4 | 16 |
| 2003 | 6 | 28 |
| 2004 | 8 | 18 |
| 2005 | 10 | 15 |
| 2006 | 9 | 22 |
| 2007 | 5 | 20 |
| 2008 | 2 | 18 |
| 2009 | 4 | 38 |
| 2010 | 12 | 35 |
| 2011 | 14 | 48 |
| 2012 | 9 | 40 |
| 2013 | 21 | 42 |
| 2014 | 29 | 55 |
| 2015 | 34 | 59 |
| 2016 | 39 | 72 |
| 2017 | 47 | 47 |
| 2018 | 28 | 67 |
| 2019 | 40 | 56 |
| 2020 | 37 | 67 |
| 2021 | 46 | 83 |
| 2022 | 37 | 59 |
| 2023 | 34 | 78 |
| 2024 | 34 | 52 |
| 2025 | 39 | 48 |
| 2026 | 17 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Formulations and methods for treating diarrhea25 Aug 2026US 12,714,687 B2
- Methods of treating hepatic encephalopathy4 Aug 2026US 12,697,326 B2Salix Pharmaceuticals, Inc.
- Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system23 Jun 2026US 12,661,412 B2University of Massachusetts
- Serpin production2 Jun 2026US 12,644,094 B2Societe des Produits Nestle S. A.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Double site-directed antibody-functional molecular conjugate, and preparation method therefor and use thereof24 Sep 2026US 2026/0285946 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Non-Enzymatic Debriding Agent and Method of Use Thereof27 Aug 2026US 2026/0248749 A1Alira Health Boston LLC
- Fat composition comprising tributyrin and tricaproin and its use in milk replacers27 Aug 2026US 2026/0248756 A1
- Chondroitin- and Collagen Peptide-Based Methods for Slowing Down Aging and Extending Lifespan27 Aug 2026US 2026/0248840 A1
- Method for controlling membrane potential-dependent ion channel through type i taste receptors (t1rs)20 Aug 2026US 2026/0240820 A1Ion Chat Research Corporate
Most cited
By later US patents
- Probiotic compositions containing clostridiales for inhibiting inflammation118US 9,610,307 B2Evelop Biosciences, Inc. · 2017
- Sustained release formulations87US 6,992,065 B2Durect Corporation · 2006
- Pharmaceutical materials and methods for their preparation and use78US 7,001,892 B1Purdue Research Foundation · 2006
- Dietary supplement nutrient soft drink composition with psychoactive effect62US 6,261,589 B12001
- Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase52US 5,866,120 AAdvanced Corneal Systems, Inc. · 1999